Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Additionally, the recent approval of a competing treatment for obstructive sleep apnea, Zepbound, could potentially divert patients away from Inspire’s offerings, affecting the company’s sales ...

The soft launch of the Inspire V neurostimulator has commenced, with over 40 implants completed, demonstrating continued innovation and ... from obstructive sleep apnea. Disclaimer: This is ...

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81.

MINNEAPOLIS, Minn, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems ... invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary, unaudited ...

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81. Jim Cramer Predicts Palantir Buying Surge Tonight After Morgan ...